A phase i study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer
J. P. Arnoletti, A. Frolov, M. Eloubeidi, K. Keene, J. Posey, T. Wood, Edward Greeno, N. Jhala, S. Varadarajulu, S. Russo, J. Christein, R. Oster, D. J. Buchsbaum, S. M. Vickers
Dive into the research topics of 'A phase i study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer'. Together they form a unique fingerprint.